Citius pharmaceuticals reschedules participation in sidoti small-cap virtual investor conference for november 2023

Cranford, n.j. , sept. 18, 2023 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, has rescheduled its participation in sidoti's small-cap virtual conference to november 2023 due to funeral services for the late howard safir, a long-time member of the citius board.
CTXR Ratings Summary
CTXR Quant Ranking